{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:46:24Z","timestamp":1754484384231,"version":"3.37.3"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07397"],"award-info":[{"award-number":["20K07397"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006728","name":"Kitasato University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with ovarian clear cell carcinoma (OCCC) experience frequent recurrence, which is most likely due to chemoresistance. We used shotgun proteomics analysis and identified upregulation of ezrin-binding phosphoprotein 50 (EBP50) in recurrent OCCC samples. Cytoplasmic and\/or nuclear (Cyt\/N), but not membranous, EBP50 immunoreactivity was significantly higher in recurrent OCCC as compared with that of primary tumors. OCCC cells expressing cytoplasmic EBP50 were significantly less susceptible to cisplatin (CDDP)-induced apoptosis compared with cells expressing membranous EBP50. Abrogation of resistance following knockdown of cytoplasmic EBP50 was accompanied by decreased XIAP and BCL2, increased BAX and increased caspase-3 cleavage. We found that poly (ADP-ribose) polymerase1 (PARP1), which is involved in DNA damage detection and repair, binds to EBP50 through its PDZ1 domain. CDDP treatment of cells expressing cytoplasmic (but not membranous) EBP50 increased nuclear PARP1 expression, whereas knockdown of EBP50 cells decreased PARP1 expression and activity following CDDP treatment. Finally, OCCC patients with a combination of Cyt\/N EBP50 and high PARP1 score had worst the prognosis for overall and progression-free survival. Together, our data suggest that cytoplasmic EBP50 inhibits apoptosis and promotes OCCC survival through stabilization of PARP1 activity and modulation of the XIAP\/BCL2\/BAX axis. This may increase the likelihood of tumor recurrence, and we therefore suggest a combined analysis for EBP50 and PARP1 may have great utility in OCCC prediction and prognosis.<\/jats:p>","DOI":"10.1093\/carcin\/bgab070","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T19:13:27Z","timestamp":1627499607000},"page":"1162-1170","source":"Crossref","is-referenced-by-count":10,"title":["Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma"],"prefix":"10.1093","volume":"42","author":[{"given":"Toshihide","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Ako","family":"Yoki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Ryo","family":"Konno","sequence":"additional","affiliation":[{"name":"Center for Disease Proteomics, School of Science, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Yasuko","family":"Oguri","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Miki","family":"Hashimura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Masataka","family":"Tochimoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Mayu","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Zesong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Yu","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]},{"given":"Yoshio","family":"Kodera","sequence":"additional","affiliation":[{"name":"Center for Disease Proteomics, School of Science, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5366-7149","authenticated-orcid":false,"given":"Makoto","family":"Saegusa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan"}]}],"member":"286","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"2021100509124864600_CIT0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"2021100509124864600_CIT0002","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6601537","article-title":"TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival","volume":"90","author":"Wang","year":"2004","journal-title":"Br. J. Cancer"},{"key":"2021100509124864600_CIT0003","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021100509124864600_CIT0004","first-page":"260","article-title":"Deregulated miR-296\/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer","volume":"6","author":"Yan","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"2021100509124864600_CIT0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0090-8258(89)90637-9","article-title":"Ovarian clear cell adenocarcinoma","volume":"32","author":"Kennedy","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"2021100509124864600_CIT0006","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/gyno.1993.1117","article-title":"Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages","volume":"49","author":"O\u2019Brien","year":"1933","journal-title":"Gynecol. Oncol."},{"key":"2021100509124864600_CIT0007","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"2021100509124864600_CIT0008","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","article-title":"Do clear cell ovarian carcinoma have poorer prognosis compared to other epithelial types? A study of 1411 clear cell ovarian cancers","volume":"109","author":"Chan","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"2021100509124864600_CIT0009","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1349-7006.2008.00747.x","article-title":"Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma","volume":"99","author":"Itamochi","year":"2008","journal-title":"Cancer Sci."},{"key":"2021100509124864600_CIT0010","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.3802\/jgo.2016.27.e31","article-title":"Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives","volume":"27","author":"Mabuchi","year":"2016","journal-title":"J. Gynecol. Oncol."},{"key":"2021100509124864600_CIT0011","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1634\/theoncologist.11-10-1089","article-title":"Treatment issues in clear cell carcinoma of the ovary: a different entity?","volume":"11","author":"Pectasides","year":"2006","journal-title":"Oncologist"},{"key":"2021100509124864600_CIT0012","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1016\/j.febslet.2013.08.026","article-title":"Breast cancer-derived K172N, D301V mutations abolish Na+\/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling","volume":"587","author":"Cheng","year":"2013","journal-title":"FEBS Lett."},{"key":"2021100509124864600_CIT0013","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/onc.2016.462","article-title":"Role of the PDZ-scaffold protein NHERF1\/EBP50 in cancer biology: from signaling regulation to clinical relevance","volume":"36","author":"Vaquero","year":"2017","journal-title":"Oncogene"},{"key":"2021100509124864600_CIT0014","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1074\/jbc.M114.609768","article-title":"Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) by Akt promotes stability and mitogenic function of S-phase kinase-associated protein-2 (Skp2)","volume":"290","author":"Song","year":"2015","journal-title":"J. Biol. Chem."},{"key":"2021100509124864600_CIT0015","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3892\/ijo.2014.2805","article-title":"The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells","volume":"46","author":"Bellizzi","year":"2015","journal-title":"Int. J. Oncol."},{"key":"2021100509124864600_CIT0016","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1210\/en.2011-1207","article-title":"Na(+)\/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression","volume":"152","author":"Yang","year":"2011","journal-title":"Endocrinology"},{"key":"2021100509124864600_CIT0017","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1038\/emm.2017.88","article-title":"Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation","volume":"49","author":"Oh","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"2021100509124864600_CIT0018","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1593\/neo.10780","article-title":"NHERF1\/EBP50 is a new marker in colorectal cancer","volume":"12","author":"Hayashi","year":"2010","journal-title":"Neoplasia"},{"key":"2021100509124864600_CIT0019","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mrrev.2017.09.004","article-title":"Poly-ADP ribosylation in DNA damage response and cancer therapy","volume":"780","author":"Hou","year":"2019","journal-title":"Mutat. Res."},{"key":"2021100509124864600_CIT0020","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/biof.1688","article-title":"An assessment of poly (ADP-ribose) polymerase-1 role in normal and cancer cells","volume":"46","author":"Kumar","year":"2020","journal-title":"Biofactors"},{"key":"2021100509124864600_CIT0021","doi-asserted-by":"crossref","first-page":"63646","DOI":"10.18632\/oncotarget.18882","article-title":"Identification of LEFTY as a molecular marker for ovarian clear cell carcinoma","volume":"8","author":"Akiya","year":"2017","journal-title":"Oncotarget"},{"key":"2021100509124864600_CIT0022","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mc.22816","article-title":"TGF-\u03b2-mediated LEFTY\/Akt\/GSK-3\u03b2\/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinoma","volume":"57","author":"Matsumoto","year":"2018","journal-title":"Mol. Carcinog."},{"key":"2021100509124864600_CIT0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12964-020-00580-3","article-title":"Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype","volume":"18","author":"Yokoi","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"2021100509124864600_CIT0024","first-page":"11","article-title":"Tumours of the tumours of the ovary.","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Longacre","year":"2014"},{"key":"2021100509124864600_CIT0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41374-019-0359-x","article-title":"S100A4\/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma","volume":"100","author":"Tochimoto","year":"2020","journal-title":"Lab. Invest."},{"key":"2021100509124864600_CIT0026","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J","article-title":"Apoptosis. Its significance in cancer and cancer therapy","volume":"73","author":"Kerr","year":"1994","journal-title":"Cancer"},{"key":"2021100509124864600_CIT0027","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","article-title":"Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2","volume":"22","author":"Xia","year":"2006","journal-title":"Mol. Cell"},{"key":"2021100509124864600_CIT0028","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"Song","year":"2005","journal-title":"J. Cell. Mol. Med."},{"key":"2021100509124864600_CIT0029","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1172\/JCI45661","article-title":"Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and \u03b2-catenin interactions","volume":"122","author":"Lin","year":"2012","journal-title":"J. Clin. Invest."},{"key":"2021100509124864600_CIT0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/156652408785748031","article-title":"Roles of NHERF1\/EBP50 in cancer","volume":"8","author":"Georgescu","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"2021100509124864600_CIT0031","doi-asserted-by":"crossref","first-page":"10283","DOI":"10.18632\/oncotarget.7184","article-title":"Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation","volume":"7","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"key":"2021100509124864600_CIT0032","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1128\/MCB.20.22.8352-8363.2000","article-title":"Platelet-derived growth factor association with Na+\/H+ exchanger regulatory factor potentiates receptor activity","volume":"20","author":"Maudsley","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"2021100509124864600_CIT0033","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/jid.2015.154","article-title":"PRL-3 promotes the malignant progression of melanoma via triggering dephosphorylation and cytoplasmic localization of NHERF1","volume":"135","author":"Fang","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"2021100509124864600_CIT0034","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/cdd.2012.4","article-title":"Phosphorylation of EBP50 negatively regulates \u03b2-PIX-dependent Rac1 activity in anoikis","volume":"19","author":"Chen","year":"2012","journal-title":"Cell Death Differ."},{"key":"2021100509124864600_CIT0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.devcel.2014.08.027","article-title":"A molecular switch for the orientation of epithelial cell polarization","volume":"31","author":"Bryant","year":"2014","journal-title":"Dev. Cell"},{"key":"2021100509124864600_CIT0036","first-page":"4587","article-title":"XIAP impairs mitochondrial function during apoptosis by regulating the Bcl-2 family in renal cell carcinoma","volume":"15","author":"Chen","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"2021100509124864600_CIT0037","doi-asserted-by":"crossref","first-page":"65730","DOI":"10.18632\/oncotarget.19444","article-title":"NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients","volume":"8","author":"Mangia","year":"2017","journal-title":"Oncotarget"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgab070\/39859770\/bgab070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/42\/9\/1162\/40508742\/bgab070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/42\/9\/1162\/40508742\/bgab070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T18:53:17Z","timestamp":1633546397000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/42\/9\/1162\/6330601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,7,29]]},"published-print":{"date-parts":[[2021,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgab070","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"type":"print","value":"0143-3334"},{"type":"electronic","value":"1460-2180"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,7,29]]}}}